Crystal Jurkiewicz’s Post

Episode 13 of our NAMSA’s MedTech Matters Series, features an in-depth look at the APEX Program Advantage for start up clients and clients outsourcing parts of their development program with a trusted partner. Tune in to hear from Michael Tar (Global Consulting Sales Strategist at NAMSA) and Marwan Berrada (CEO & Founder at Advanced Nano Therapies) discuss the strategic advantages of the APEX Program in MedTech. Make sure to catch this insightful episode to stay informed and competitive in the dynamic MedTech landscape. Watch Here -> https://lnkd.in/eNqTu64j #NAMSAKnows #MedTechMatters #MedicalDevices

Episode 13 of our NAMSA’s MedTech Matters Series, features an in-depth look at the APEX Program Advantage for start up clients and clients outsourcing parts of their development program with a trusted partner.   Tune in to hear from Michael Tar (Global Consulting Sales Strategist at NAMSA) and Marwan Berrada (CEO & Founder at Advanced Nano Therapies) discuss the strategic advantages of the APEX Program in MedTech.   Make sure to catch this insightful episode to stay informed and competitive in the dynamic MedTech landscape. Watch Here -> https://lnkd.in/g94ZSAuB   #NAMSAKnows #MedTechMatters #MedicalDevices

Episode 13 of our NAMSA’s MedTech Matters Series, features an in-depth look at the APEX Program Advantage for start up clients and clients outsourcing parts of their development program with a trusted partner.   Tune in to hear from Michael Tar (Global Consulting Sales Strategist at NAMSA) and Marwan Berrada (CEO & Founder at Advanced Nano Therapies) discuss the strategic advantages of the APEX Program in MedTech.   Make sure to catch this insightful episode to stay informed and competitive in the dynamic MedTech landscape. Watch Here -> https://lnkd.in/gSGm8tFN   #NAMSAKnows #MedTechMatters #MedicalDevices

The APEX Program Advantage: Episode 13 of our NAMSA’s MedTech Matters Series, features an in-depth look at the APEX Program Advantage for start up clients and clients outsourcing parts of their development program with a trusted partner.   Tune in to hear from Michael Tar (Global Consulting Sales Strategist at NAMSA) and Marwan Berrada (CEO & Founder at Advanced Nano Therapies) discuss the strategic advantages of the APEX Program in MedTech.   Make sure to catch this insightful episode to stay informed and competitive in the dynamic MedTech landscape.   Watch Here -> https://lnkd.in/gRz6DeWJ   #NAMSAKnows #MedTechMatters #MedicalDevices

Introducing our latest blog 📣 Mastering objection handlers is essential for driving success in market access activities within the pharma and MedTech industries. Priscila Mazzola, PhD, Head of Value Communication at MAP shares four essential tips for effective objection handlers in this blog. Discover our expert tips for crafting compelling objection handlers – paving the way to successful reimbursement. Read more here: https://lnkd.in/eExMHvuA #blog #objectionhandlers #ValueCommunication

For our final 🏁 post of the week, we cover the last of our founder case studies from our annual MedTech 2024 report. We spoke to Chas Taylor, a serial #entrepreneur and seasoned MedTech device #expert. In this episode, we cover Chas’ experience with Veryan Medical, a company that specialises in creating innovative stents for vascular disease treatment. This highly concentrated and competitive market required careful navigation. With years of experience, Chas gave us clear-set guidance on how to strive for success on the commercialisation journey: 🌎 Kickstart market expansion networks for rapid international growth ⏳ Dive into discussions with regulators and payers early on 🔭 Zoom in on go-to-market and marketing strategy Even though Veryan Medical faced a challenging market during the COVID-19 pandemic, after adjusting accordingly, the company was successfully acquired by Otsuka Medical Devices Co., Ltd. Keep an eye out for our posts next week where we dive into case studies from industry experts 👀 Chas Taylor Esther Reynal de St Michel Richardot Tatum Getty Pamela Walker Saran Davies #vascular #medicaldevice #regulatory #international #medtech

Excited to take part in #Biomed2024 and bring #marketing_innovation to the forefront of #medtech. Join me for a series of #GoToMarket #expert consultations for congress attendees. Don't miss this opportunity to advance your market understanding and discover how to generate #growth through #smart #marketing strategies. I invite you to schedule a meeting with me through the congress platform. The number of slots is limited. I look forward to meeting you soon! MedTech Marketing at Scale #biotech #healthtech #medicaldevices #medicalmarketing #marketingexpert #marketingstrategy #growthmarketing #digitalmarketing #cmoservices #cmo #marketingplanning #tradeshowmarketing

Great News! Ortho-tag's OPS, an advanced alert diagnostic tool for joint infection, has been selected for the MedTech Innovator Road Show 2024! "We are proud to announce that Ortho-tag, a pioneer of in-body communication and biosensing on the nanoscale, has been chosen to compete among 80 companies. Selected from a pool of more than 1,400 applicants Ortho-tag will present during the global MedTech Innovator Road Tour in April, 2024. MedTech Innovator is the largest accelerator of medical technology companies in the world, supporting companies that are transforming the healthcare system. The Ortho-tag team will present its in-body, battery-free, communication and advanced alert diagnostic tool for Periprosthetic Joint Infection (PJI). PJI is a serious post-operative complication that is a potential life-threatening risk for the patient and a challenge for early detection. Ortho-tag’s pH nanosensor, designed to attach to, or integrate with, an orthopaedic implant, measures and stores the pH level surrounding a joint replacement, serving as an early indicator of potential infection. A proprietary external reader powers and transmits the pH reading to a digital interface, providing clinicians with a real-time observation of pH changes that improve decision making and enhance patient outcomes." #medicaldevices #diseasemanagement #funding #healthcare #biosensing #venturecapital #digitalhealth

Meditrial is excited to attend the National Regulatory Conference in #Bern on October 17, 2024! As the Swiss medtech industry faces complex regulatory challenges, we look forward to connecting with companies to share insights and tailored strategies to elevate your innovations. #RegulatoryConference #Meditrial #SwissMedtech #Bern2024 #WeAreMeditrial Swiss Medtech, Meditrial, Jennifer Braaten

Value-based contracts have the potential to mitigate the inherent financial and/or clinical uncertainties associated with making innovative drugs available for patients. Explore the optimal conditions under which different types of VBCs are suitable to maximize success. https://lnkd.in/dq7jpTT9 If you would like to learn more about VBCs and #medtech, connect with our team at The MedTech Forum this week in Vienna. #valuebased #valuebasedhealthcare #MTF2024